USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF THE PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PSUMMIT I STUDY

被引:0
|
作者
McInnes, I. B. [1 ]
Kavanaugh, A. [2 ]
Gottlieb, A. B. [3 ]
Puig, L. [4 ]
Rahman, P. [5 ]
Ritchlin, C. [6 ]
Li, S. [7 ]
Wang, Y. [7 ]
Mendelsohn, A. M. [7 ]
Doyle, M. K. [7 ,8 ]
机构
[1] U Glasgow, Glasgow, Lanark, Scotland
[2] U Calif, San Diego, CA USA
[3] Tufts Med Cntr, Boston, MA USA
[4] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[5] Mem U, St John, NF, Canada
[6] U Rochester, Rochester, NY USA
[7] Janssen R&D, Spring House, PA USA
[8] U Penn, Philadelphia, PA USA
关键词
D O I
10.1136/annrheumdis-2012-eular.1841
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:107 / 107
页数:1
相关论文
共 50 条
  • [1] Ustekinumab in Patients with Active Psoriatic Arthritis: Results of the Phase 3, Multicenter, Double-blind, Placebo-Controlled PSUMMIT I Study
    Rahman, Proton
    Kavanaugh, Arthur
    Gottlieb, Alice
    Puig, Lluis
    Ritchlin, Christopher
    McInnes, Iain
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan
    Doyle, Mittie
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 983 - 983
  • [2] Ustekinumab in Patients with Active Psoriatic Arthritis: Results of the Phase 3, Multicenter, Double-Blind, Placebo-Controlled Psummit I Study
    Kavanaugh, Arthur
    McInnes, Iain B.
    Gottlieb, Alice B.
    Puig, Lluis
    Rahman, Proton
    Ritchlin, Christopher T.
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan
    Doyle, Mittie K.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1083 - S1084
  • [3] Ustekinumab in patients with active psoriatic arthritis: Results of the phase III, multicenter, double-blind, placebo-controlled PSUMMIT I study
    Gottlieb, Alice
    Kavanaugh, Arthur
    McInnes, Iain
    Puig, Lluis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB218 - AB218
  • [4] USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS OF THE PHASE III, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED PSUMMIT I STUDY
    McInnes, Iain
    Kavanaugh, Arthur
    Gottlieb, Alice B.
    Puig, Lluis
    Rahman, Proton
    Ritchlin, Christopher
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan
    Doyle, Mittie
    RHEUMATOLOGY, 2013, 52 : 164 - 164
  • [5] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 1 Year Results of the Phase 3, Multicentre, Double-Blind, Placebo-Controlled PSUMMIT 1 Trial
    Lunzer, R.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2013, 20 (04): : 175 - 176
  • [6] Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
    McInnes, Iain B.
    Kavanaugh, Arthur
    Gottlieb, Alice B.
    Puig, Lluis
    Rahman, Proton
    Ritchlin, Christopher
    Brodmerkel, Carrie
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan M.
    Doyle, Mittie K.
    LANCET, 2013, 382 (9894): : 780 - 789
  • [7] EFFICACY AND SAFETY OF USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Kavanaugh, A.
    Puig, L.
    Gottlieb, A.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Song, M.
    Rahman, P.
    McInnes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 737 - 738
  • [8] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-Year Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
    Kavanaugh, Arthur
    Puig, Luis
    Gottlieb, Alice B.
    Ritchlin, Christopher T.
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan
    Song, Michael
    Rahman, Proton
    McInnes, Iain B.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3323 - 3324
  • [9] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-year Results From a Phase 3, Multicenter, Double-blind, Placebo-controlled Study
    Kavanaugh, A.
    Puig, L.
    Gottlieb, A. B.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Song, M.
    Rahman, P.
    McInnes, I.
    SWISS MEDICAL WEEKLY, 2014, 144 : 8S - 9S
  • [10] Ustekinumab in Active Psoriatic Arthritis Including Patients Previously Treated with Anti-TNF Agents: Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
    Ritchlin, Christopher T.
    Gottlieb, Alice B.
    McInnes, Iain B.
    Puig, Lluis
    Rahman, Proton
    Li, Shu
    Wang, Yuhua
    Doyle, Mittie K.
    Mendelsohn, Alan
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1080 - S1081